Little is really known about health care and the pharmaceutical industry in Iran, but several recent IRNA news agency announcements have shed some light on developments there. The following are summaries of these items:
- The Razi Research Center in Iran's Mazandaran province is currently producing 2 billion doses of vaccines and serums each year, saving Iran some $60 million in imports. The center produces 23 types of vaccines and four kinds of serums for the treatment of poisoning, as well as other medicines.
- Iranian and Georgian officials signed an agreement for bilateral cooperation in the chemical and pharmaceutical industries during a recent visit of Iranian President Rafsanjani to Tbilisi, the Georgian capital. It was also mentioned that Georgia may use Iranian transit facilities for its exports and imports;
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze